International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma

Research output: Contribution to journalArticlepeer-review

Standard

International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma. / Dimopoulos, M; Terpos, E; Comenzo, R L; Tosi, P; Beksac, M; Sezer, O; Siegel, D; Lokhorst, H; Kumar, S; Rajkumar, S V; Niesvizky, R; Moulopoulos, L A; Durie, B G M; IMWG ; Wheatley, Keith.

In: Leukemia, Vol. 23, No. 9, 09.2009, p. 1545-56.

Research output: Contribution to journalArticlepeer-review

Harvard

Dimopoulos, M, Terpos, E, Comenzo, RL, Tosi, P, Beksac, M, Sezer, O, Siegel, D, Lokhorst, H, Kumar, S, Rajkumar, SV, Niesvizky, R, Moulopoulos, LA, Durie, BGM, IMWG & Wheatley, K 2009, 'International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma', Leukemia, vol. 23, no. 9, pp. 1545-56. https://doi.org/10.1038/leu.2009.89

APA

Dimopoulos, M., Terpos, E., Comenzo, R. L., Tosi, P., Beksac, M., Sezer, O., Siegel, D., Lokhorst, H., Kumar, S., Rajkumar, S. V., Niesvizky, R., Moulopoulos, L. A., Durie, B. G. M., IMWG, & Wheatley, K. (2009). International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma. Leukemia, 23(9), 1545-56. https://doi.org/10.1038/leu.2009.89

Vancouver

Author

Dimopoulos, M ; Terpos, E ; Comenzo, R L ; Tosi, P ; Beksac, M ; Sezer, O ; Siegel, D ; Lokhorst, H ; Kumar, S ; Rajkumar, S V ; Niesvizky, R ; Moulopoulos, L A ; Durie, B G M ; IMWG ; Wheatley, Keith. / International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma. In: Leukemia. 2009 ; Vol. 23, No. 9. pp. 1545-56.

Bibtex

@article{81e9b9da06bb4573a637b57dc52997de,
title = "International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma",
abstract = "Several imaging technologies are used for the diagnosis and management of patients with multiple myeloma (MM). Conventional radiography, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear medicine imaging are all used in an attempt to better clarify the extent of bone disease and soft tissue disease in MM. This review summarizes all available data in the literature and provides recommendations for the use of each of the technologies. Conventional radiography still remains the 'gold standard' of the staging procedure of newly diagnosed and relapsed myeloma patients. MRI gives information complementary to skeletal survey and is recommended in MM patients with normal conventional radiography and in all patients with an apparently solitary plasmacytoma of bone. Urgent MRI or CT (if MRI is not available) is the diagnostic procedure of choice to assess suspected cord compression. Bone scintigraphy has no place in the routine staging of myeloma, whereas sequential dual-energy X-ray absorptiometry scans are not recommended. Positron emission tomography/CT or MIBI imaging are also not recommended for routine use in the management of myeloma patients, although both techniques may be useful in selected cases that warrant clarification of previous imaging findings, but such an approach should ideally be made within the context of a clinical trial.",
keywords = "Absorptiometry, Photon, Bone Neoplasms, Humans, Magnetic Resonance Imaging, Multiple Myeloma, Paraproteinemias, Plasmacytoma, Positron-Emission Tomography, Prognosis, Technetium Tc 99m Sestamibi, Tomography, X-Ray Computed",
author = "M Dimopoulos and E Terpos and Comenzo, {R L} and P Tosi and M Beksac and O Sezer and D Siegel and H Lokhorst and S Kumar and Rajkumar, {S V} and R Niesvizky and Moulopoulos, {L A} and Durie, {B G M} and IMWG and Keith Wheatley",
year = "2009",
month = sep,
doi = "10.1038/leu.2009.89",
language = "English",
volume = "23",
pages = "1545--56",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "9",

}

RIS

TY - JOUR

T1 - International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma

AU - Dimopoulos, M

AU - Terpos, E

AU - Comenzo, R L

AU - Tosi, P

AU - Beksac, M

AU - Sezer, O

AU - Siegel, D

AU - Lokhorst, H

AU - Kumar, S

AU - Rajkumar, S V

AU - Niesvizky, R

AU - Moulopoulos, L A

AU - Durie, B G M

AU - IMWG

AU - Wheatley, Keith

PY - 2009/9

Y1 - 2009/9

N2 - Several imaging technologies are used for the diagnosis and management of patients with multiple myeloma (MM). Conventional radiography, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear medicine imaging are all used in an attempt to better clarify the extent of bone disease and soft tissue disease in MM. This review summarizes all available data in the literature and provides recommendations for the use of each of the technologies. Conventional radiography still remains the 'gold standard' of the staging procedure of newly diagnosed and relapsed myeloma patients. MRI gives information complementary to skeletal survey and is recommended in MM patients with normal conventional radiography and in all patients with an apparently solitary plasmacytoma of bone. Urgent MRI or CT (if MRI is not available) is the diagnostic procedure of choice to assess suspected cord compression. Bone scintigraphy has no place in the routine staging of myeloma, whereas sequential dual-energy X-ray absorptiometry scans are not recommended. Positron emission tomography/CT or MIBI imaging are also not recommended for routine use in the management of myeloma patients, although both techniques may be useful in selected cases that warrant clarification of previous imaging findings, but such an approach should ideally be made within the context of a clinical trial.

AB - Several imaging technologies are used for the diagnosis and management of patients with multiple myeloma (MM). Conventional radiography, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear medicine imaging are all used in an attempt to better clarify the extent of bone disease and soft tissue disease in MM. This review summarizes all available data in the literature and provides recommendations for the use of each of the technologies. Conventional radiography still remains the 'gold standard' of the staging procedure of newly diagnosed and relapsed myeloma patients. MRI gives information complementary to skeletal survey and is recommended in MM patients with normal conventional radiography and in all patients with an apparently solitary plasmacytoma of bone. Urgent MRI or CT (if MRI is not available) is the diagnostic procedure of choice to assess suspected cord compression. Bone scintigraphy has no place in the routine staging of myeloma, whereas sequential dual-energy X-ray absorptiometry scans are not recommended. Positron emission tomography/CT or MIBI imaging are also not recommended for routine use in the management of myeloma patients, although both techniques may be useful in selected cases that warrant clarification of previous imaging findings, but such an approach should ideally be made within the context of a clinical trial.

KW - Absorptiometry, Photon

KW - Bone Neoplasms

KW - Humans

KW - Magnetic Resonance Imaging

KW - Multiple Myeloma

KW - Paraproteinemias

KW - Plasmacytoma

KW - Positron-Emission Tomography

KW - Prognosis

KW - Technetium Tc 99m Sestamibi

KW - Tomography, X-Ray Computed

U2 - 10.1038/leu.2009.89

DO - 10.1038/leu.2009.89

M3 - Article

C2 - 19421229

VL - 23

SP - 1545

EP - 1556

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 9

ER -